Keppra and Relafen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Keppra (levetiracetam) and Relafen (nabumetone). Common drug interactions include intervertebral disc protrusion among females and arrhythmia among males.
The phase IV clinical study analyzes what interactions people have when they take Keppra and Relafen. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
What is Relafen?
Relafen has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 6,243 Relafen users. Check the latest studies of Relafen.
19 people who take Keppra and Relafen together, and have interactions are studied.

What are the common drug interactions of Keppra and Relafen, by gender? *:
female:
- Intervertebral disc protrusion (spinal disc protrusion)
- Laryngitis (inflammation of the larynx)
- Leukopenia (less number of white blood cells in blood)
- Leukoplakia (white and gray patches inside the mouth)
- Limb discomfort (discomfort in leg)
- Lip disorder (disease of lip)
- Lumbar vertebral fracture
- Headache (pain in head)
- Ataxia (loss of full control of bodily movements)
- Confusional state
male:
- Arrhythmia (irregular heartbeat)
- Avulsion fracture (bone fracture)
- Oedema (fluid collection in tissue)
- Personality disorder
- Type 2 diabetes mellitus
- Unresponsive to stimuli
- Back pain
- Contusion (a type of hematoma of tissue in which capillaries)
- Death
- Drug toxicity
What are the common drug interactions of Keppra and Relafen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Avulsion fracture (bone fracture)
- Back pain
- Blood alkaline phosphatase increased
- Contusion (a type of hematoma of tissue in which capillaries)
- Headache (pain in head)
- Hyperglycaemia (high blood sugar)
- Hypersensitivity
- Intervertebral disc degeneration (spinal disc degeneration)
40-49:
- Arrhythmia (irregular heartbeat)
- Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Drug ineffective
- Drug toxicity
- Dysphagia (a condition in which swallowing is difficult or painful)
- Hunger
- Interstitial lung disease
- Nausea (feeling of having an urge to vomit)
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
50-59:
- Hypersomnia (excessive daytime sleepiness (eds))
- Hypertension (high blood pressure)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Hypotension (abnormally low blood pressure)
- Intervertebral disc protrusion (spinal disc protrusion)
- Limb discomfort (discomfort in leg)
- Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
- Memory impairment
- Migraine (headache)
- Myopathy (a muscular disease in which the muscle fibres do not function)
60+:
- Confusional state
- Aggression
- Muscular weakness (muscle weakness)
- Neuropathy peripheral (surface nerve damage)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Anaemia (lack of blood)
- Cardiac arrest
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
What are the existing conditions these people have? *
- Pain: 6 people, 31.58%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 21.05%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.79%
- Infection: 2 people, 10.53%
- Muscle Aches (muscle pain): 2 people, 10.53%
- Muscle Spasms (muscle contraction): 2 people, 10.53%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 10.53%
- Osteoporosis (bones weak and more likely to break): 2 people, 10.53%
- Wheezing (a high-pitched whistling sound made while you breath): 2 people, 10.53%
- Pneumonia: 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take Keppra and Relafen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Keppra and Relafen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Relafen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keppra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Relafen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levetiracetam and nabumetone (the active ingredients of Keppra and Relafen, respectively), and Keppra and Relafen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Flexeril cause Drug Level Decreased? - 5 seconds ago
- Drug interactions of Cimzia and Calcium Carbonate - 21 seconds ago
- Could Elspar cause Heart Rate Increased? - 39 seconds ago
- Drug interactions of Eligard and Gabapentin - 39 seconds ago
- Drug interactions of Garlic and Ticagrelor - 46 seconds ago
- Drug interactions of Escitalopram Oxalate and Cellcept - a minute ago
- Drug interactions of Vitamin D3 and Inderal - a minute ago
- Drug interactions of Digoxin and Gleevec - a minute ago
- Drug interactions of Bactrim and Prohance - a minute ago
- Could Glucophage cause Tinea Infection? - a minute ago